Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Inflammatory Bowel Diseases

  Free Subscription

Articles published in Mediators Inflamm

Retrieve available abstracts of 35 articles:
HTML format

Single Articles

    January 2021
  1. YOSHIMURA T, Mitsuyama K, Sakemi R, Takedatsu H, et al
    Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease.
    Mediators Inflamm. 2021;2021:8825374.
    PubMed     Abstract available

    January 2020
  2. SAMARANI S, Sagala P, Jantchou P, Grimard G, et al
    Phenotypic and Functional Changes in Peripheral Blood Natural Killer Cells in Crohn Disease Patients.
    Mediators Inflamm. 2020;2020:6401969.
    PubMed     Abstract available

  3. RODRIGUEZ-CANALES M, Martinez-Galero E, Nava-Torres AD, Sanchez-Torres LE, et al
    Anti-Inflammatory and Antioxidant Activities of the Methanolic Extract of Cyrtocarpa procera Bark Reduces the Severity of Ulcerative Colitis in a Chemically Induced Colitis Model.
    Mediators Inflamm. 2020;2020:5062506.
    PubMed     Abstract available

  4. CAMARILLO GF, Goyon EI, Zuniga RB, Salas LAS, et al
    Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis.
    Mediators Inflamm. 2020;2020:9238970.
    PubMed     Abstract available

  5. DING X, Bin P, Wu W, Chang Y, et al
    Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review.
    Mediators Inflamm. 2020;2020:9706140.
    PubMed     Abstract available

  6. SHAO X, Yang L, Hu K, Shen R, et al
    Serum Cholinesterases, a Novel Marker of Clinical Activity in Inflammatory Bowel Disease: A Retrospective Case-Control Study.
    Mediators Inflamm. 2020;2020:4694090.
    PubMed     Abstract available

  7. HA J, Oh H, Oh NS, Seo Y, et al
    Anti-Inflammatory Effect of a Peptide Derived from the Synbiotics, Fermented Cudrania tricuspidata with Lactobacillus gasseri, on Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:3572809.
    PubMed     Abstract available

  8. ZHU L, Li Y, Zhou L, Yang G, et al
    Role of RING-Type E3 Ubiquitin Ligases in Inflammatory Signalling and Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:5310180.
    PubMed     Abstract available

  9. XIN Z, Zhai Z, Long H, Zhang F, et al
    Metabolic Profiling by UPLC-Orbitrap-MS/MS of Liver from C57BL/6 Mice with DSS-Induced Inflammatory Bowel Disease.
    Mediators Inflamm. 2020;2020:6020247.
    PubMed     Abstract available

  10. LIN J, Li G, Xu C, Lu H, et al
    Monocyte Chemotactic Protein 1-Induced Protein 1 Is Highly Expressed in Inflammatory Bowel Disease and Negatively Regulates Neutrophil Activities.
    Mediators Inflamm. 2020;2020:8812020.
    PubMed     Abstract available

    January 2019
  11. NING L, Lou X, Zhang F, Xu G, et al
    Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:2624941.
    PubMed     Abstract available

  12. ZHAO X, Li L, Li X, Li J, et al
    The Relationship between Serum Bilirubin and Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:5256460.
    PubMed     Abstract available

  13. HAN L, Wang XM, Di S, Gao ZZ, et al
    Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks.
    Mediators Inflamm. 2019;2019:1978094.
    PubMed     Abstract available

  14. LI J, Zhao X, Li X, Lu M, et al
    Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis.
    Mediators Inflamm. 2019;2019:2136501.
    PubMed     Abstract available

  15. MA C, Vasu R, Zhang H
    The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:8495913.
    PubMed     Abstract available

  16. SHU W, Pang Z, Xu C, Lin J, et al
    Anti-TNF-alpha Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease.
    Mediators Inflamm. 2019;2019:4038619.
    PubMed     Abstract available

  17. KANG J, Zhang Z, Wang J, Wang G, et al
    hucMSCs Attenuate IBD through Releasing miR148b-5p to Inhibit the Expression of 15-lox-1 in Macrophages.
    Mediators Inflamm. 2019;2019:6953963.
    PubMed     Abstract available

    January 2018
  18. GRZYBOWSKA-CHLEBOWCZYK U, Wysocka-Wojakiewicz P, Jasielska M, Cukrowska B, et al
    Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic Inflammatory Process.
    Mediators Inflamm. 2018;2018:4120973.
    PubMed     Abstract available

  19. BOROS E, Kellermayer Z, Balogh P, Strifler G, et al
    Elevated Expression of AXL May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients.
    Mediators Inflamm. 2018;2018:3241406.
    PubMed     Abstract available

  20. TOLEDO-MAURINO JJ, Furuzawa-Carballeda J, Villeda-Ramirez MA, Fonseca-Camarillo G, et al
    The Transient Receptor Potential Vanilloid 1 Is Associated with Active Inflammation in Ulcerative Colitis.
    Mediators Inflamm. 2018;2018:6570371.
    PubMed     Abstract available

  21. CHARPENTIER C, Chan R, Salameh E, Mbodji K, et al
    Dietary n-3 PUFA May Attenuate Experimental Colitis.
    Mediators Inflamm. 2018;2018:8430614.
    PubMed     Abstract available

  22. DIGE A, Magnusson MK, Uhrenholt C, Rasmussen TK, et al
    Effects of Anti-TNFalpha Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's Disease.
    Mediators Inflamm. 2018;2018:3279607.
    PubMed     Abstract available

  23. LENNON EM, Borst LB, Edwards LL, Moeser AJ, et al
    Mast Cells Exert Anti-Inflammatory Effects in an IL10(-/-) Model of Spontaneous Colitis.
    Mediators Inflamm. 2018;2018:7817360.
    PubMed     Abstract available

  24. ZHANG C, Shu W, Zhou G, Lin J, et al
    Anti-TNF-alpha Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease.
    Mediators Inflamm. 2018;2018:3021863.
    PubMed     Abstract available

  25. OZ HS, Yeh SL, Amedei A
    Gut Inflammatory Diseases, Infection, and Nutrition.
    Mediators Inflamm. 2018;2018:7160859.

    January 2017
  26. RAFA H, Benkhelifa S, AitYounes S, Saoula H, et al
    All-Trans Retinoic Acid Modulates TLR4/NF-kappaB Signaling Pathway Targeting TNF-alpha and Nitric Oxide Synthase 2 Expression in Colonic Mucosa during Ulcerative Colitis and Colitis Associated Cancer.
    Mediators Inflamm. 2017;2017:7353252.
    PubMed     Abstract available

  27. BAO X, Feng Z, Yao J, Li T, et al
    Roles of Dietary Amino Acids and Their Metabolites in Pathogenesis of Inflammatory Bowel Disease.
    Mediators Inflamm. 2017;2017:6869259.
    PubMed     Abstract available

  28. GUAN Q, Zhang J
    Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.
    Mediators Inflamm. 2017;2017:4810258.
    PubMed     Abstract available

  29. DUVOISIN G, Lopez RN, Day AS, Lemberg DA, et al
    Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease.
    Mediators Inflamm. 2017;2017:1936315.
    PubMed     Abstract available

  30. CORETTI L, Natale A, Cuomo M, Florio E, et al
    The Interplay between Defensins and Microbiota in Crohn's Disease.
    Mediators Inflamm. 2017;2017:8392523.
    PubMed     Abstract available

    January 2016
  31. RODRIGUEZ-CANALES M, Jimenez-Rivas R, Canales-Martinez MM, Garcia-Lopez AJ, et al
    Protective Effect of Amphipterygium adstringens Extract on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice.
    Mediators Inflamm. 2016;2016:8543561.
    PubMed     Abstract available

  32. BRYAN PF, Karla C, Edgar Alejandro MT, Sara Elva EP, et al
    Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease.
    Mediators Inflamm. 2016;2016:9890141.
    PubMed     Abstract available

  33. ZHOU G, Yu L, Yang W, Wu W, et al
    Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease.
    Mediators Inflamm. 2016;2016:2543070.
    PubMed     Abstract available

  34. PHILLIPS-FARFAN B, Carvajal K, Medina-Torres EA, Espinosa-Padilla SE, et al
    Corrigendum to "Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease".
    Mediators Inflamm. 2016;2016:7267956.
    PubMed     Abstract available

  35. KHAWAR MB, Abbasi MH, Sheikh N
    IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis.
    Mediators Inflamm. 2016;2016:8413768.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.